The startup develops DNA-modifying technologies utilizing molecular genetics and bioinformatics, including genetic modifications and machine learning with deep neural networks. Their services enable clients to conduct biotechnological research for genetically modified cell lines and molecular cloning, enhancing research efficiency and precision.
Funding
$470K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Researchers often face challenges in accessing cutting-edge molecular genetics and bioinformatics techniques, hindering their ability to conduct advanced biotechnological research. Traditional methods can be time-consuming, require specialized expertise, and may not be readily accessible to all researchers.
Solution
DeepBiotech provides personalized next-generation sequencing and molecular biology services, accelerating access to advanced techniques such as molecular cloning, CRISPR/Cas9-based genetic modifications, and deep neural network-based machine learning. The company offers customized analysis and ready-to-use materials, including personalized figures, documentation, and in-depth analysis, tailored to specific project needs. By de-risking experiments through expert guidance and AI support, DeepBiotech ensures successful outcomes within shortened timelines, delivering swift and completely personalized solutions for research, publication, patent submission, and development. As a contract research organization (CRO), DeepBiotech leverages emerging techniques, such as machine learning and specialized assays, to maximize project scope and quality, ensuring forward-thinking research solutions backed by the latest technological advancements.
Target Audience
DeepBiotech's primary customers are academic and university researchers, biomedical researchers, neuroscientists, plant biologists, entomologists, bioinformaticians, geneticists, evolutionary biologists, immunologists, microbiologists, and oncologists seeking personalized genomics services.
Features
- Molecular cloning services for creating custom DNA vector constructs, including promoter and selection marker identification, 2D and 3D modeling, and gene synthesis
- Genetically modified cell line services using CRISPR/Cas9 technology for gene knockouts, knock-ins, and precise gene modifications
- CRO services offering comprehensive solutions tailored to unique research needs, including personalized molecular cloning, next-generation sequencing, and CRISPR/Cas9 cell lines
- Whole genome sequencing services providing customized analysis, genetic landscape mapping, variant detection, and comparative genomics
- Whole RNA sequencing services offering customized transcriptome sequencing, differential gene expression analysis, novel transcript identification, and splice variant analysis
- SMRT sequencing services for long-read sequencing, structural variation detection, complex genomic region analysis, and epigenetic methylation landscape mapping
- AI-assisted protein and RNA design, in silico testing, and cloning strategy
- Next-generation sequencing validation and mutational landscape analysis
- Ready-to-use materials and methods, QC reports, and personalized analyses